Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

MAIA Biotechnology, Inc. Common Stock (NY:MAIA)

1.780 UNCHANGED
Streaming Delayed Price Updated: 12:14 PM EDT, Apr 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MAIA Biotechnology, Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
JOANN And 3 Other Stocks Under $4 Insiders Are Aggressively Buying
The Dow Jones closed slightly lower on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny... 
Via Benzinga
MAIA Biotechnology Announces Excellent Efficacy of THIO in Liver Cancer Models
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology to Present at AACR Annual Meeting 2023
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology Touts Positive Data From Healthy Volunteer Study Of Potential Lung Cancer Candidate
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
MAIA Biotechnology Reports Positive Topline Data from Part A Safety Lead-In of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology Reports Full Year 2022 Financial Results and Provides Corporate Update
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology And 2 Other Stocks Under $5 Insiders Are Aggressively Buying
The Dow Jones closed lower by more than 500 points on Wednesday following Fed’s rate decision. When insiders purchase or sell shares, it indicates their confidence or concern around the company's... 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 74 companies achieved new lows for the year. 
Via Benzinga
MAIA Biotechnology Announces No Exposure to Silicon Valley Bank
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology Doses First Patients in Europe in Ongoing Phase 2 Trial (THIO-101) Evaluating THIO for Non-Small Cell Lung Cancer Treatment
From MAIA Biotechnology, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023
Via Benzinga
ADDING MULTIMEDIA: MAIA Biotechnology’s Telomere-targeting Agent THIO, in Combination With Checkpoint Inhibitor Immune Therapies Atezolizumab (anti-PD-L1) or Pembrolizumab (anti-PD-1), Demonstrated Significantly Greater Tumor Inhibition
From MAIA Biotechnology, Inc.
Via Business Wire
Insiders Buying Adamas One And 1 Other Penny Stock
The Nasdaq recorded gains for the fourth week in a row. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested... 
Via Benzinga
Sidoti's January Micro-Cap Conference
Via ACCESSWIRE
MAIA Biotechnology Advances New Telomere-Targeting Molecule Program
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology to Participate in Four Upcoming Investor Conferences
From MAIA Biotechnology, Inc.
Via Business Wire
CalAmp And 2 Other Stocks Under $5 Insiders Are Aggressively Buying
The Dow Jones settled higher by over 300 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
MAIA Biotechnology Holds Successful Pre-IND Meeting with FDA for Planned US Expansion of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology Expands Phase 2 THIO-101 Trial to Europe
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology Announces Establishment of Rule 10b5-1 Trading Plan
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology Presents Preclinical Data at SITC Annual Meeting Validating Efficacy of THIO in Treating Hepatocellular Carcinoma
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology Reports Third Quarter 2022 Financial Results and Provides Corporate Update
From MAIA Biotechnology, Inc.
Via Business Wire
Sidoti's November Micro-Cap Virtual Conference
Via ACCESSWIRE
MAIA Biotechnology to Participate in ThinkEquity Conference
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology to Present at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology to Participate in H.C. Wainwright 24th Annual Global Investment Conference
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology to Present Design of THIO-101 Trial at European Society for Medical Oncology (ESMO) Congress 2022
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology to Present Anticancer THIO Platform at XIV International Round Table on Nucleosides, Nucleotides, and Nucleic Acids
From MAIA Biotechnology, Inc.
Via Business Wire
MAIA Biotechnology Reports Second Quarter 2022 Financial Results and Provides Corporate Update
From MAIA Biotechnology, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.